Skip to main content

Delayed Graft Function

2
Pipeline Programs
5
Companies
6
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Astellas
AstellasChina - Shenyang
2 programs
1
azathioprinePhase 41 trial
Role of T Helper 17 and Regulatory T Cells in Delayed Graft FunctionN/A1 trial
Active Trials
NCT01232816Unknown50Est. Dec 2019
NCT00321906Completed181Est. Aug 2011
Corline Biomedical
Corline BiomedicalSweden - Uppsala
1 program
1
RenaparinPhase 11 trial
Active Trials
NCT03773211Completed16Est. Apr 2020
Biocorp
BiocorpFrance - Issoire
1 program
No treatmentN/A1 trial
Active Trials
NCT02335333Completed35Est. Dec 2015
argenx
argenxBelgium - Zwijnaarde
1 program
ARGX-117PHASE_21 trial
Active Trials
NCT05907096Active Not Recruiting103Est. Jul 2026
Veloxis Pharmaceuticals
1 program
Envarsus XRPHASE_41 trial
Active Trials
NCT03864926Completed100Est. Jul 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Veloxis PharmaceuticalsEnvarsus XR
Astellasazathioprine
argenxARGX-117
Corline BiomedicalRenaparin
BiocorpNo treatment
AstellasRole of T Helper 17 and Regulatory T Cells in Delayed Graft Function

Clinical Trials (6)

Total enrollment: 485 patients across 6 trials

NCT03864926Veloxis PharmaceuticalsEnvarsus XR

Envarsus in Delayed Graft Function (E-DGF)

Start: Mar 2019Est. completion: Jul 2022100 patients
Phase 4Completed
NCT00321906Astellasazathioprine

Comparison of Sirolimus and Azathioprine in Lung Transplantation

Start: Apr 2002Est. completion: Aug 2011181 patients
Phase 4Completed
NCT05907096argenxARGX-117

ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function

Start: Feb 2024Est. completion: Jul 2026103 patients
Phase 2Active Not Recruiting
NCT03773211Corline BiomedicalRenaparin

Renaparin® in Kidney Transplantation

Start: Feb 2019Est. completion: Apr 202016 patients
Phase 1Completed
NCT02335333BiocorpNo treatment

Biomarkers of Aging as Predictors of Kidney Transplant Function

Start: Jan 2015Est. completion: Dec 201535 patients
N/ACompleted
NCT01232816AstellasRole of T Helper 17 and Regulatory T Cells in Delayed Graft Function

Role of T Helper 17 and Regulatory T Cells in Delayed Graft Function

Start: Jul 2010Est. completion: Dec 201950 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.